ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

1nHealth Partners With The Mighty to Bring Fresh Patient Centricity to Clinical Trial Recruitment

1nHealth presented 941 total patients with opportunities to join relevant online communities with The Mighty

1nHealth and The Mighty
1nHealth and The Mighty

1nHealth Partners With The Mighty to Bring Fresh Patient Centricity to Clinical Trial Recruitment

Clinical trials bring hope to patients by exposing them to potentially groundbreaking therapies. Thus, it can be especially devastating for patients to learn about a clinical trial and then fail to qualify for participation.  

1nHealth and The Mighty have teamed up to route patients who may not qualify for a specific trial to condition-focused communities on The Mighty where those patients can get support, read stories that provide representation, and be part of a community of those with similar health journeys. Patient Centricity means keeping the focus on people, and this partnership enables that to extend all the way to the recruitment stage. 

"Teaming up with 1nHealth is such a great opportunity," says President of The Mighty Matthew Michelson, Ph.D. "The Mighty is here for patients in need, especially when the chips are down. And when patients hear about potential live-changing therapies and then can't participate, that's a blow. Now, at that exact point, they'll be directed to communities on The Mighty that identify with their struggle — and that deep representation and community is powerful." 

The process begins when a patient clicks on a 1nHealth study advertisement for a specific clinical trial. On 1nHealth's study screener, a patient submits their information. If a patient fails to meet the inclusion criteria for the trial, they are presented with opportunities to engage with communities of relevance on The Mighty. Patients can then join those communities and be part of the conversation. 

"We often see support for patient centricity in a performative way," says 1nHealth CEO Dan Brenner. "At 1nHealth, we want to serve all patients, not just the patients who qualify for a study. Those who submit their information in prescreening are clearly looking for help, and we want to be a resource for them even if that specific trial cannot be the solution. This partnership with The Mighty furthers our mission to put patients first." 

To date, the partnership combined on multiple studies, presenting 941 patients the opportunity to join relevant communities on The Mighty. 1nHealth and The Mighty will continue to implement this offering for clients who opt in.  

Contact Information:
Albany Alexander
Growth Manager at 1nHealth
albany.alexander@1nhealth.com
4076004693

Matt Michelson
President of The Mighty
sales@themighty.com


Original Source: 1nHealth Partners With The Mighty to Bring Fresh Patient Centricity to Clinical Trial Recruitment
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.